A 1536-Well Fluorescence Polarization Assay to Screen for Modulators of the MUSASHI Family of RNA-Binding Proteins
Journal:
Combinatorial Chemistry & High Throughput Screening
Volume:
17
Page:
596-609
Author(s):
Gerard Minuesa, Christophe Antczak, David Shum, Constantin Radu, Bhavneet Bhinder, Yueming Li, Hakim Djaballah and Michael G. Kharas
Phosphoproteomics as a Promising Tool for Broadening the Analysis of Clinical Samples and for the Fight Against Cancer Disease
Journal:
Current Pharmaceutical Analysis
Volume:
10
Page:
223-229
Author(s):
Natalia Miekus and Tomasz Baczek
Heat Shock Protein 90 Inhibitors in Oncology
Journal:
Current Proteomics
Volume:
11
Page:
2-16
Author(s):
Aykut Ozgur and Yusuf Tutar
From the Table to the Bedside: Can Food-Derived Sulforaphane be used as a Novel Agent to Treat Leukemia?
Journal:
Current Cancer Drug Targets
Volume:
14
Page:
434-445
Author(s):
Koramit Suppipat and H. Daniel Lacorazza
Signaling Pathways Modulating Dependence of Lung Cancer on Mutant Epidermal Growth Factor Receptor and Mechanisms of Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
3883-3893
Author(s):
Luciano Wannesson, Santiago Viteri, Carlota Costa, Niki Karachaliou, Miguel Angel Molina-Vila and Rafael Rosell
MET and ALK as Targets for the Treatment of NSCLC
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
3914-3932
Author(s):
Capelletti M, Gelsomino F. and Tiseo M.
Galectins: Major Signaling Modulators Inside and Outside the Cell
Journal:
Current Molecular Medicine
Volume:
14
Page:
630-651
Author(s):
D. Compagno, F.M. Jaworski, L. Gentilini, G. Contrufo, I. Gonzalez Perez, M.T. Elola, N. Pregi, G.A. Rabinovich and D.J. Laderach
miR-1271 Regulates Cisplatin Resistance of Human Gastric Cancer Cell Lines by Targeting IGF1R, IRS1, mTOR, and BCL2
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
14
Page:
884-891
Author(s):
Mifang Yang, Xia Shan, Xin Zhou, Tianzhu Qiu, Wei Zhu, Yin Ding, Yongqian Shu and Ping Liu
Fused Aryl-Phenazines: Scaffold for the Development of Bioactive Molecules
Journal:
Current Drug Targets
Volume:
15
Page:
681-688
Author(s):
N.S. Hari Narayana Moorthy, Vijayakumari Pratheepa, Maria J. Ramos, Vitor Vasconcelos and Pedro A. Fernandes
Preclinical Drug Metabolism and Pharmacokinetics, and Prediction of Human Pharmacokinetics and Efficacious Dose of the Investigational Aurora A Kinase Inhibitor Alisertib (MLN8237)
Journal:
Drug Metabolism Letters
Volume:
7
Page:
96-104
Author(s):
Johnny J. Yang, Yu Li, Arijit Chakravarty, Chuang Lu, Cindy Q. Xia, Susan Chen, Sandeep Pusalkar, Mengkun Zhang, Jeffrey Ecsedy, Mark G. Manfredi, Jing-Tao Wu, Wen Chyi Shyu and Suresh K. Balani